Methotrexate in the combination therapy of juvenile idiopathic arthritis

The paper discusses whether biological agents (BAs) may be used as monotherapy. The combination of different BAs and methotrexate (MTX) allows a good result in patients with juvenile idiopathic arthritis refractory to standard antirheumatic therapy. The efficiency of this therapy meets the ACRpedi50...

Full description

Bibliographic Details
Main Authors: E. S. Zholobova, М. N. Nikolaeva, S. N. Chebysheva, A. V. Meleshkina, O. Yu. Loskutova, L. A. Galstyan, E. Yu. Afonina
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2018-09-01
Series:Современная ревматология
Subjects:
Online Access:https://mrj.ima-press.net/mrj/article/view/849

Similar Items